NR 4-5/2004

get MSIE 4.x or better from www.microsoft.com/ie

Toksyna botulinowa A w leczeniu oczopl±su wrodzonego u dzieci

Botulinum toxin A in the treatment of congenital nystagmus in children

Ewa Oleszczyńska-Prost

Z Centrum Okulistyki Dziecięcej w Warszawie
Kierownik: dr n. med. Ewa Oleszczyńska-Prost

Summary: Purpose: To evaluate the use of, botulinum toxin A in the treatment of congenital nystagmus in children.
Material and methods: 32 children with nystagmus and esotropia (group I), nystagmus and exotropia (group II) and horizontal and vertical nystagmus (group III). Intramuscular injections of botulinum toxin A was performed in all treated children.
Results: In group I the amplitude of nystagmus diminished of 50%, in group II of 42.9% and in group III of 28,6%. Near and distant visual acuity improved in all treated children.
Conclusions: Treatment of congenital nystagmus with botulinum toxin A causes reduction of the amplitude of nystagmus, partial improvement of visual acuity and improvement of anomalous head posture.
Słowa kluczowe:  Słowa kluczowe: oczopl±s wrodzony, dzieci, leczenie, toksyna botulinowa typu A.
Key words: Key words: congenital nystagmus, children, treatment, botulinum toxin A.



linia-lewa.gif (150 bytes)


Wydawca dwumiesięcznika medycznego "Klinika Oczna"
Oftal Sp. z o.o.

ul. Lindleya4, 02-005 Warszawa
Oddział: 03-709 Warszawa ul. Sierakowskiego 13 (Szpital)

tel./fax: (0-22) 670-47-40
centrala: (0-22) 618-84-85 wew. 52-45

e-mail: ored@okulistyka.com.pl